Cargando…

Targeted Deep Sequencing Reveals Unrecognized KIT Mutation Coexistent with NF1 Deficiency in GISTs

PURPOSE: NF1-deficient GISTs account for about 1% of gastrointestinal stromal tumors (GISTs) and are usually considered as a subtype of KIT/PDGFRA wild-type GISTs that have no detectable KIT and PDGFRA mutations. Some KIT/PDGFRA wild-type GISTs actually have cryptic KIT mutations (mKIT). So we inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jinchun, Zhou, Haiyan, Yi, Xiaoping, He, Qiongzhi, Lei, Tianxiang, Tan, Fengbo, Liu, Heli, Li, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811451/
https://www.ncbi.nlm.nih.gov/pubmed/33469372
http://dx.doi.org/10.2147/CMAR.S280174
_version_ 1783637498288668672
author Wu, Jinchun
Zhou, Haiyan
Yi, Xiaoping
He, Qiongzhi
Lei, Tianxiang
Tan, Fengbo
Liu, Heli
Li, Bin
author_facet Wu, Jinchun
Zhou, Haiyan
Yi, Xiaoping
He, Qiongzhi
Lei, Tianxiang
Tan, Fengbo
Liu, Heli
Li, Bin
author_sort Wu, Jinchun
collection PubMed
description PURPOSE: NF1-deficient GISTs account for about 1% of gastrointestinal stromal tumors (GISTs) and are usually considered as a subtype of KIT/PDGFRA wild-type GISTs that have no detectable KIT and PDGFRA mutations. Some KIT/PDGFRA wild-type GISTs actually have cryptic KIT mutations (mKIT). So we investigate whether concurrent mKIT existed in NF1-associated GISTs. PATIENTS AND METHODS: Three independent cohorts were retrospectively analyzed. KIT/PDGFRA wild-type GISTs in Xiangya Hospital between May 2017 and Oct 2019 were investigated by next-generation sequencing (NGS) approach targeted 1021 cancer-related genes regions. GISTs cases in Gene+ dataset from May 2017 to May 2020 were collected from the platform of this company. The genotypes of GISTs in MSKCC cohort were downloaded from cBioPortal. RESULTS: A total of 290 cases including 23 KIT/PDGFRA wild-type GISTs in Xiangya Hospital, 136 GISTs in Gene+ database, and 131 GISTs in MSKCC were enrolled. Twenty-six cases have NF1 mutations (mNF1), and 48% (12/26) of NF1-mutated GISTs have concurrent mKIT. Compared with MSKCC (2/10, 20%), a higher ratio of mKIT in NF1-associated GISTs was detected in Xiangya Hospital (3/5, 60%) and Gene+ (7/11, 64%) (p<0.05). No mutation hotspot existed in mNF1. Most of mKIT centered within exon 11 (7/12, 58%) and others including exon 17 (3/12, 25%), exon 9(1/12, 8%), exon 13 (1/12, 8%) and exon 21 (1/12, 8%). No differences in age, gender, and location were detected between NF1-related GISTs with mKIT and those without mKIT. Three GIST cases of type I neurofibromatosis, skin neurofibromas and micro-GISTs (≤1 cm) were devoid of mKIT, but all the mini-GISTs (1~2 cm) and clinic GIST lesions (>2 cm) in two cases harbored mKIT. CONCLUSION: mKIT was not unusual in NF1-associated GISTs, especially in Chinese populations. The gain-of-function mKIT possibly facilitated the progression of NF1-deficient lesions to clinic GISTs, however, the underlying mechanism warrants further studies.
format Online
Article
Text
id pubmed-7811451
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78114512021-01-18 Targeted Deep Sequencing Reveals Unrecognized KIT Mutation Coexistent with NF1 Deficiency in GISTs Wu, Jinchun Zhou, Haiyan Yi, Xiaoping He, Qiongzhi Lei, Tianxiang Tan, Fengbo Liu, Heli Li, Bin Cancer Manag Res Original Research PURPOSE: NF1-deficient GISTs account for about 1% of gastrointestinal stromal tumors (GISTs) and are usually considered as a subtype of KIT/PDGFRA wild-type GISTs that have no detectable KIT and PDGFRA mutations. Some KIT/PDGFRA wild-type GISTs actually have cryptic KIT mutations (mKIT). So we investigate whether concurrent mKIT existed in NF1-associated GISTs. PATIENTS AND METHODS: Three independent cohorts were retrospectively analyzed. KIT/PDGFRA wild-type GISTs in Xiangya Hospital between May 2017 and Oct 2019 were investigated by next-generation sequencing (NGS) approach targeted 1021 cancer-related genes regions. GISTs cases in Gene+ dataset from May 2017 to May 2020 were collected from the platform of this company. The genotypes of GISTs in MSKCC cohort were downloaded from cBioPortal. RESULTS: A total of 290 cases including 23 KIT/PDGFRA wild-type GISTs in Xiangya Hospital, 136 GISTs in Gene+ database, and 131 GISTs in MSKCC were enrolled. Twenty-six cases have NF1 mutations (mNF1), and 48% (12/26) of NF1-mutated GISTs have concurrent mKIT. Compared with MSKCC (2/10, 20%), a higher ratio of mKIT in NF1-associated GISTs was detected in Xiangya Hospital (3/5, 60%) and Gene+ (7/11, 64%) (p<0.05). No mutation hotspot existed in mNF1. Most of mKIT centered within exon 11 (7/12, 58%) and others including exon 17 (3/12, 25%), exon 9(1/12, 8%), exon 13 (1/12, 8%) and exon 21 (1/12, 8%). No differences in age, gender, and location were detected between NF1-related GISTs with mKIT and those without mKIT. Three GIST cases of type I neurofibromatosis, skin neurofibromas and micro-GISTs (≤1 cm) were devoid of mKIT, but all the mini-GISTs (1~2 cm) and clinic GIST lesions (>2 cm) in two cases harbored mKIT. CONCLUSION: mKIT was not unusual in NF1-associated GISTs, especially in Chinese populations. The gain-of-function mKIT possibly facilitated the progression of NF1-deficient lesions to clinic GISTs, however, the underlying mechanism warrants further studies. Dove 2021-01-12 /pmc/articles/PMC7811451/ /pubmed/33469372 http://dx.doi.org/10.2147/CMAR.S280174 Text en © 2021 Wu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wu, Jinchun
Zhou, Haiyan
Yi, Xiaoping
He, Qiongzhi
Lei, Tianxiang
Tan, Fengbo
Liu, Heli
Li, Bin
Targeted Deep Sequencing Reveals Unrecognized KIT Mutation Coexistent with NF1 Deficiency in GISTs
title Targeted Deep Sequencing Reveals Unrecognized KIT Mutation Coexistent with NF1 Deficiency in GISTs
title_full Targeted Deep Sequencing Reveals Unrecognized KIT Mutation Coexistent with NF1 Deficiency in GISTs
title_fullStr Targeted Deep Sequencing Reveals Unrecognized KIT Mutation Coexistent with NF1 Deficiency in GISTs
title_full_unstemmed Targeted Deep Sequencing Reveals Unrecognized KIT Mutation Coexistent with NF1 Deficiency in GISTs
title_short Targeted Deep Sequencing Reveals Unrecognized KIT Mutation Coexistent with NF1 Deficiency in GISTs
title_sort targeted deep sequencing reveals unrecognized kit mutation coexistent with nf1 deficiency in gists
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811451/
https://www.ncbi.nlm.nih.gov/pubmed/33469372
http://dx.doi.org/10.2147/CMAR.S280174
work_keys_str_mv AT wujinchun targeteddeepsequencingrevealsunrecognizedkitmutationcoexistentwithnf1deficiencyingists
AT zhouhaiyan targeteddeepsequencingrevealsunrecognizedkitmutationcoexistentwithnf1deficiencyingists
AT yixiaoping targeteddeepsequencingrevealsunrecognizedkitmutationcoexistentwithnf1deficiencyingists
AT heqiongzhi targeteddeepsequencingrevealsunrecognizedkitmutationcoexistentwithnf1deficiencyingists
AT leitianxiang targeteddeepsequencingrevealsunrecognizedkitmutationcoexistentwithnf1deficiencyingists
AT tanfengbo targeteddeepsequencingrevealsunrecognizedkitmutationcoexistentwithnf1deficiencyingists
AT liuheli targeteddeepsequencingrevealsunrecognizedkitmutationcoexistentwithnf1deficiencyingists
AT libin targeteddeepsequencingrevealsunrecognizedkitmutationcoexistentwithnf1deficiencyingists